Drug profile · INN
fesoterodine fumarate
FESOTERODINE FUMARATE
fesoterodine fumarate (FESOTERODINE FUMARATE) is a muscarinic acetylcholine receptor m2 antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — fesoterodine fumarate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
fesoterodine fumarate (FESOTERODINE FUMARATE) is a muscarinic acetylcholine receptor m2 antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Muscarinic acetylcholine receptor M2 antagonist
Primary target: Muscarinic acetylcholine receptor M2
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is fesoterodine fumarate?
fesoterodine fumarate (FESOTERODINE FUMARATE) is a muscarinic acetylcholine receptor m2 antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for fesoterodine fumarate?
FESOTERODINE FUMARATE is a marketed brand name for fesoterodine fumarate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fesoterodine fumarate?
fesoterodine fumarate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.